Pfizer's Avastin biosimilar wins FDA approval

Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news